stockrow
Saturday 7 November 2026
Export AHR’s income statement to Excel — free account
American Healthcare REIT, Inc.
AHR Real Estate Reit Healthcare Facilities
American Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 9.15% from fiscal 2024.
- Revenue
- +29.5%
- EPS
- −57.6%
- Free cash flow
- +9.53%
- Total debt
- −64.6%
Quarter to September 2026, against a year earlier
57.92
1.88
+3.35%
Follow AHR
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
7 | 7 | 5 | 5 | 3 | 6 | — | — | — |
P/E ratio |
114.78 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
3.46 | 1.79 | 0.47 | 0.47 | 0.47 | 0.47 | 0.47 | 0.47 | 0.47 |
P/FCF ratio |
36.16 | 16.47 | 4.76 | 4.76 | 4.76 | 4.76 | 4.76 | 4.76 | 4.76 |
P/Operating CF |
141.66 | 62.39 | 33.88 | 33.88 | 33.88 | 33.88 | 33.88 | 33.88 | 33.88 |
P/B ratio |
2.33 | 1.61 | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 |
Price to Tangible BV |
2.72 | 1.95 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 |
EV/Sales |
4.08 | 2.56 | 1.79 | 1.79 | 1.79 | 1.79 | 1.79 | 1.79 | 1.79 |
EV/EBITDA |
23.69 | 15.07 | 10.51 | 10.51 | 10.51 | 10.51 | 10.51 | 10.51 | 10.51 |
EV/Operating CF |
31.29 | 30.07 | 34.00 | 34.00 | 34.00 | 34.00 | 34.00 | 34.00 | 34.00 |
EV/FCF |
42.64 | 23.49 | 18.28 | 18.28 | 18.28 | 18.28 | 18.28 | 18.28 | 18.28 |
Quick Ratio |
0.41 | 0.35 | 0.19 | 0.16 | 0.18 | 0.27 | 0.05 | 0.08 | — |
Current Ratio |
0.41 | 0.35 | 0.19 | 0.16 | 0.18 | 0.27 | 0.05 | 0.08 | — |
Net Debt/EBITDA |
3.60 | 4.50 | 7.77 | 7.90 | 12.30 | 6.90 | 1.84 | 8.67 | 0.00 |
Debt/Assets |
28.58% | 38.00% | 56.10% | 53.48% | 51.43% | 52.01% | 39.58% | 32.56% | 0.00% |
Debt/Equity |
0.46 | 0.74 | 1.80 | 1.63 | 1.34 | 1.63 | 0.72 | 0.52 | 0.00 |
Asset Turnover |
0.46 | 0.46 | 0.40 | 0.35 | 0.33 | 0.58 | 1.25 | 0.19 | 0.00 |
Operating CF/Net income |
4.22 | (4.66) | (1.38) | (1.82) | (0.37) | 101.32 | (23.66) | (1.85) | 22.93 |
Capex/Depreciation |
(0.35) | 0.22 | 0.34 | (0.10) | (0.48) | (0.89) | (0.65) | (0.13) | (0.08) |
Interest Coverage |
1.89 | 1.02 | 0.43 | 0.82 | 0.33 | 1.23 | 1.09 | (0.25) | 1.19 |
| 2.46% | (2.03%) | (4.78%) | (4.89%) | (3.42%) | 0.27% | (0.87%) | 0.00% | 0.00% | |
| 1.41% | (0.83%) | (1.53%) | (1.74%) | (1.22%) | 0.10% | (0.51%) | (1.86%) | 0.00% | |
ROIC |
2.15% | 2.09% | 1.14% | 1.34% | 0.38% | 2.24% | 5.04% | (0.13%) | 0.00% |
Return on Tangible Assets |
1.90% | (1.37%) | (3.20%) | (3.53%) | (2.04%) | 0.14% | (1.02%) | (1.89%) | 0.00% |
Average Days of Receivables |
33.00 | 37.21 | 36.25 | 30.54 | 34.95 | 36.54 | 1.38 | 48.62 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
2.60% | 2.30% | 2.55% | 2.64% | 3.37% | 2.17% | 2.43% | 10.86% | 13.01% |
Intangible Assets out of Total Assets |
0.09 | 0.09 | 0.09 | 0.10 | 0.10 | 0.07 | 0.07 | 0.08 | 0.00 |
Share Based Compensation of Revenue |
0.65% | 0.48% | 0.29% | 0.24% | 0.75% | (0.10%) | 0.24% | 0.22% | 0.39% |
Graham Net Nets |
(0.22) | (0.50) | (3.29) | (3.29) | (3.29) | (3.29) | (3.29) | (3.29) | (3.29) |
Graham Number |
13.66 | 0.00 | 0.00 | 0.00 | 0.00 | 10.10 | 0.00 | 0.00 | 2.28 |
Earnings Yield |
0.87% | (0.95%) | (8.44%) | (8.44%) | (8.44%) | (8.44%) | (8.44%) | (8.44%) | (8.44%) |
Free Cash Flow Yield |
2.77% | 6.07% | 20.99% | 20.99% | 20.99% | 20.99% | 20.99% | 20.99% | 20.99% |
Revenue per Share |
13.61 | 15.85 | 28.26 | 24.97 | 25.60 | 27.66 | 26.89 | 1.54 | 1.20 |
Operating CF per Share |
1.77 | 1.35 | 1.49 | 2.25 | 0.36 | 4.87 | 2.58 | 0.28 | 0.45 |
Capex per Share |
(0.47) | 0.38 | 1.28 | (0.35) | (1.50) | (2.57) | (2.01) | (0.08) | (0.04) |
Free Cash Flow per Share |
1.30 | 1.73 | 2.77 | 1.89 | (1.14) | 2.30 | 0.57 | 0.20 | 0.41 |
Cash per Share |
0.91 | 0.94 | 1.37 | 1.70 | 2.51 | 3.38 | 0.35 | 0.27 | 0.00 |
Shareholders Equity per Share |
20.24 | 17.64 | 21.58 | 23.82 | 35.08 | 23.00 | 12.97 | 10.17 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
20.24 | 17.64 | 21.58 | 23.82 | 35.08 | 23.00 | 12.97 | 10.17 | 0.00 |
Free Cash Flow |
216.09 | 225.42 | 183.28 | 124.55 | (57.28) | 103.38 | 25.85 | 11.17 | 11.28 |
Working Capital |
(511.44) | (612.45) | (1,190.71) | (1,276.22) | (1,166.49) | (761.56) | (409.39) | (290.14) | — |
Capital Expenditures |
(78.35) | 49.33 | 84.74 | (23.22) | (75.20) | (115.78) | (91.61) | (4.26) | (1.12) |
Net Current Asset Value |
(1,709.54) | (1,849.71) | (2,876.44) | (2,969.53) | (2,575.23) | (1,923.71) | (457.79) | (312.86) | 0.00 |
EV/EBIT |
56.26 | 40.84 | 47.24 | 47.24 | 47.24 | 47.24 | 47.24 | 47.24 | 47.24 |
Capex to Sales |
0.03 | (0.02) | (0.05) | 0.01 | 0.06 | 0.09 | 0.07 | 0.05 | 0.03 |
Price to Operating Income |
47.72 | 28.64 | 12.31 | 12.31 | 12.31 | 12.31 | 12.31 | 12.31 | 12.31 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.05 | 0.07 | 0.07 | 0.06 | 0.04 | 0.06 | 0.16 | 0.05 | 0.00 |
Cash ROIC |
4.27% | 5.45% | 4.49% | 2.94% | (1.35%) | 3.60% | 2.51% | 1.29% | 0.00% |
Accounts Receivable Turnover |
10.88 | 10.45 | 11.56 | 12.63 | 10.37 | 19.27 | 154.27 | 0.00 | 0.00 |
Accounts Payable Turnover |
6.41 | 6.81 | 6.41 | 6.21 | 5.58 | 9.01 | 27.06 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
62.86 | 55.23 | 56.84 | 66.36 | 64.24 | 69.25 | 12.04 | 360.26 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
207.71 | 198.24 | 161.44 | 130.14 | 123.67 | 64.58 | 7.93 | — | — |
Average Payables |
288.03 | 250.61 | 243.37 | 215.98 | 191.40 | 113.86 | 37.02 | — | — |
Average Assets |
4,957.14 | 4,533.00 | 4,682.32 | 4,683.52 | 3,907.64 | 2,151.63 | 982.35 | 448.19 | — |
Average Common Equity |
2,832.28 | 1,864.64 | 1,496.55 | 1,662.31 | 1,395.66 | 812.28 | 573.88 | — | — |
Columns are period end dates · fundamentals updated 6 Nov 2026